Table 1.
Code | Gender | Age | Subtype | TMN ** | Stage ** | Ov # | PDX ## | Histological Classification |
---|---|---|---|---|---|---|---|---|
D039 | F | 66 | ICC | T3N0M0 | III | No | − | WD, papillo-tubular adenocarcinoma |
D042 | M | 56 | ECC | T2bN0M0 | II | No | − | Invasive, intraductal papillary carcinoma |
D049 * | M | 55 | ICC | T2bN0M0 | II | Ov | + | WD, tubular adenocarcinoma |
D058 | F | 64 | ICC | T3N1M0 | IVA | Ov | + | WD, tubular adenocarcinoma |
D068 * | M | 61 | ICC | T2aN1M0 | IVA | No | + | WD, tubular adenocarcinoma with micropapillary foci |
D070 | M | 65 | ICC | T3N1M0 | IVA | No | + | WD, tubular adenocarcinoma |
D078 | F | 44 | ECC | T4N1M0 | IVA | No | + | WD, tubular adenocarcinoma |
D088 | F | 68 | ICC | T3N0M0 | III | No | + | MD, tubular adenocarcinoma |
D090 | F | 65 | ECC | T2bN0M0 | II | No | + | Invasive, intraductal papillary carcinoma |
D096 | M | 45 | ECC | T3N1M0 | IIIB | No | + | WD, tubular adenocarcinoma |
D106 | M | 54 | ECC | T2bN1M0 | IIIB | No | +/− | Invasive, intraductal papillary carcinoma |
D113 | M | 70 | ICC | T3N0M0 | III | No | + | Invasive, intraductal papillary carcinoma |
D117 | M | 58 | ICC | T3N1M0 | IVA | No | − | WD, tubular adenocarcinoma with micropapillary foci |
D119 | M | 71 | ECC | T3N1M0 | IIIB | No | + | WD, tubular adenocarcinoma |
D131 * | M | 66 | ICC | T3N1M0 | IVA | No | + | WD, tubular adenocarcinoma |
D138 * | F | 60 | ICC | T3N0M0 | III | No | + | Adenosquamous carcinoma |
* Cell lines were established; ** classification is based on the 7th edition of the AJCC cancer staging classification [33]; # Opisthorchis viverrini (Ov) is observed in the tissues; ## serial transplanted tissues are successfully established, +/− indicates only F0 tumor was obtained; F: female; M: male; ECC: extrahepatic cholangiocarcinoma; ICC: intrahepatic cholangiocarcinoma; MD: moderately-differentiated subtype; WD: well-differentiated subtype; PDX: patient-derived xenograft.